{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:50Z","timestamp":1794048890899,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal angiomyolipomas hemorrhage is associated with their size and vascular constitution. The effects of sirolimus on different components of angiomyolipomas was analyzed in patients with tuberous sclerosis complex, sporadic lymphangioleiomyomatosis and multiple sporadic angiomyolipomas. Thirty angiomyolipomas from 14 patients treated with sirolimus were retrospectively evaluated. A Hounsfield-unit threshold was used to classify angiomyolipomas in fat-rich, fat-poor and intermediate-fat tumors, and to categorize tumor compartments in fat rich, fat poor, intermediate fat and highly vascularized. Diameter variations were measured to assess the effects on aneurysmatic\/ectatic vascular formations. Volume reduction following treatment with sirolimus was higher in fat-poor than fat-rich angiomyolipomas. Tumor reduction was mainly determined by decrease of the fat-poor and highly-vascularized compartments while the volume of the fat-rich compartment increased. Broad liposubstitution was observed in some tumors. A median reduction of 100% (75\u00a0to\u00a0100) in the diameter of aneurysmatic\/ectatic vascular structures was observed. Our study showed that sirolimus reduces the size of angiomyolipomas by decreasing primarily their highly-vascularized and fat-poor compartments. This effect is associated with a remarkable reduction of tumoral aneurysms\/ectatic vessels, revealing the likely mechanism responsible for the risk-decreasing effect of mTOR inhibitors on angiomyolipoma bleeding. These findings support the role of mTOR in the development of angiomyolipoma blood vessels.<\/jats:p>","DOI":"10.1038\/s41598-021-87930-4","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T10:04:56Z","timestamp":1618826696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effect of sirolimus on angiomyolipoma is determined by decrease of fat-poor compartments and includes striking reduction of vascular structures"],"prefix":"10.1038","volume":"11","author":[{"given":"Elieser Hitoshi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Morbeck Almeida","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilton Le\u00e3o","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Eduardo Pedroso","family":"Balbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precil Diego Miranda de Menezes","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Maria","family":"Franzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ide","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Fernando","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"S4","key":"87930_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1464-410X.2012.11618.x","volume":"110","author":"AR Lienert","year":"2012","unstructured":"Lienert, A. R. & Nicol, D. Renal angiomyolipoma. BJU Int. 110(S4), 25\u201327 (2012).","journal-title":"BJU Int."},{"issue":"1","key":"87930_CR2","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1159\/000320891","volume":"118","author":"BP Dixon","year":"2011","unstructured":"Dixon, B. P., Hulbert, J. C. & Bissler, J. J. Tuberous sclerosis complex renal disease. Nephron Exp. Nephrol. 118(1), e15-20 (2011).","journal-title":"Nephron Exp. Nephrol."},{"issue":"5","key":"87930_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1053\/j.ajkd.2011.12.022","volume":"59","author":"AD Rule","year":"2012","unstructured":"Rule, A. D. et al. Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am. J. Kidney Dis. 59(5), 611\u2013618 (2012).","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"87930_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","volume":"66","author":"JJ Bissler","year":"2004","unstructured":"Bissler, J. J. & Kingswood, J. C. Renal angiomyolipomata. Kidney Int. 66(3), 924\u2013934 (2004).","journal-title":"Kidney Int."},{"key":"87930_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00508-015-0758-y","volume":"127","author":"S Samueli","year":"2015","unstructured":"Samueli, S. et al. Tuberous sclerosis complex: new criteria for diagnostic work-up and management. Wien. Klin. Wochenschr. 127, 1\u201312 (2015).","journal-title":"Wien. Klin. Wochenschr."},{"issue":"2","key":"87930_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pedhc.2006.05.004","volume":"21","author":"AK Leung","year":"2007","unstructured":"Leung, A. K. & Robson, W. L. Tuberous sclerosis complex: a review. J. Pediatr. Health Care 21(2), 108\u2013114 (2007).","journal-title":"J. Pediatr. Health Care"},{"issue":"10","key":"87930_CR7","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski, S. K. et al. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 70(10), 1777\u20131782 (2006).","journal-title":"Kidney Int."},{"issue":"2","key":"87930_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1148\/radiol.2252011584","volume":"225","author":"KA Casper","year":"2002","unstructured":"Casper, K. A., Donnelly, L. F., Chen, B. & Bissler, J. J. Tuberous sclerosis complex: renal imaging findings 1. Radiology 225(2), 451\u2013456 (2002).","journal-title":"Radiology"},{"issue":"2","key":"87930_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack, F. X. Lymphangioleiomyomatosis: a clinical update. Chest J. 133(2), 507\u2013516 (2008).","journal-title":"Chest J."},{"issue":"1","key":"87930_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1148\/radiol.2421051767","volume":"242","author":"NA Avila","year":"2007","unstructured":"Avila, N. A., Dwyer, A. J., Rabel, A. & Moss, J. Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features. Radiology 242(1), 277\u2013285 (2007).","journal-title":"Radiology"},{"issue":"4","key":"87930_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1378\/chest.115.4.1041","volume":"115","author":"SC Chu","year":"1999","unstructured":"Chu, S. C. et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest J. 115(4), 1041\u20131052 (1999).","journal-title":"Chest J."},{"issue":"6","key":"87930_CR12","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1164\/ajrccm.152.6.8520787","volume":"152","author":"SM Bernstein","year":"1995","unstructured":"Bernstein, S. M. et al. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis?. Am. J. Respir. Crit. Care Med. 152(6), 2138\u20132143 (1995).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"87930_CR13","first-page":"281","volume":"49","author":"M Dickinson","year":"1998","unstructured":"Dickinson, M., Ruckle, H., Beaghler, M. & Hadley, H. Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin. Nephrol. 49(5), 281\u2013286 (1998).","journal-title":"Clin. Nephrol."},{"issue":"1","key":"87930_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.ju.0000100100.36354.61","volume":"171","author":"T Harabayashi","year":"2004","unstructured":"Harabayashi, T. et al. Management of renal angiomyolipomas associated with tuberous sclerosis complex. J. Urol. 171(1), 102\u2013105 (2004).","journal-title":"J. Urol."},{"issue":"3","key":"87930_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.143.3.7079506","volume":"143","author":"R Kutcher","year":"1982","unstructured":"Kutcher, R., Rosenblatt, R., Mitsudo, S., Goldman, M. & Kogan, S. Renal angiomyolipoma with sonographic demonstration of extension into the inferior vena cava. Radiology 143(3), 755\u2013756 (1982).","journal-title":"Radiology"},{"issue":"1","key":"87930_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF02932648","volume":"9","author":"F Camunez","year":"1988","unstructured":"Camunez, F. et al. CT demonstration of extension of renal angiomyolipoma into the inferior vena cava in a patient with tuberous sclerosis. Urol. Radiol. 9(1), 152\u2013154 (1988).","journal-title":"Urol. Radiol."},{"issue":"1","key":"87930_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00007611-199701000-00013","volume":"90","author":"JE Fegan","year":"1997","unstructured":"Fegan, J. E., Shah, H. R., Mukunyadzi, P. & Schutz, M. J. Extrarenal retroperitoneal angiomyolipoma. South. Med. J. 90(1), 59\u201362 (1997).","journal-title":"South. Med. J."},{"issue":"6","key":"87930_CR18","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0022-5347(17)35895-0","volume":"150","author":"MS Steiner","year":"1993","unstructured":"Steiner, M. S., Goldman, S. M., Fishman, E. K. & Marshall, F. F. The natural history of renal angiomyolipoma. J. Urol. 150(6), 1782\u20131786 (1993).","journal-title":"J. Urol."},{"issue":"9","key":"87930_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.humpath.2007.01.028","volume":"38","author":"H Kenerson","year":"2007","unstructured":"Kenerson, H., Folpe, A. L., Takayama, T. K. & Yeung, R. S. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum. Pathol. 38(9), 1361\u20131371 (2007).","journal-title":"Hum. Pathol."},{"issue":"9366","key":"87930_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite, N., Zhang, H., Henske, E. P. & Kwiatkowski, D. J. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361(9366), 1348\u20131349 (2003).","journal-title":"Lancet"},{"issue":"1","key":"87930_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1494","volume":"37","author":"K Inoki","year":"2005","unstructured":"Inoki, K., Corradetti, M. N. & Guan, K. L. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 37(1), 19\u201324 (2005).","journal-title":"Nat Genet."},{"issue":"9869","key":"87930_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler, J. J. et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381(9869), 817\u2013824 (2013).","journal-title":"Lancet"},{"issue":"2","key":"87930_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358(2), 140\u2013151 (2008).","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"87930_CR24","doi-asserted-by":"publisher","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","volume":"6","author":"SL Dabora","year":"2011","unstructured":"Dabora, S. L. et al. Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease. PLoS ONE 6(9), e23379 (2011).","journal-title":"PLoS ONE"},{"issue":"3","key":"87930_CR25","first-page":"292","volume":"31","author":"C Cabrera L\u00f3pez","year":"2011","unstructured":"Cabrera L\u00f3pez, C. et al. Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis. Nefrologia 31(3), 292\u2013298 (2011).","journal-title":"Nefrologia"},{"issue":"12","key":"87930_CR26","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies, D. M. et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin. Cancer Res. 17(12), 4071\u20134081 (2011).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"87930_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10147-017-1224-9","volume":"23","author":"T Hatano","year":"2018","unstructured":"Hatano, T., Atsuta, M., Inaba, H., Endo, K. & Egawa, S. Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density. Int. J. Clin. Oncol. 23(3), 547\u2013552 (2018).","journal-title":"Int. J. Clin. Oncol."},{"issue":"12","key":"87930_CR28","doi-asserted-by":"publisher","first-page":"e0189132","DOI":"10.1371\/journal.pone.0189132","volume":"12","author":"S Brakemeier","year":"2017","unstructured":"Brakemeier, S. et al. Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC). PLoS ONE 12(12), e0189132 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"87930_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.2251011477","volume":"225","author":"K Yamakado","year":"2002","unstructured":"Yamakado, K. et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture 1. Radiology 225(1), 78\u201382 (2002).","journal-title":"Radiology"},{"issue":"6","key":"87930_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.crad.2006.02.003","volume":"61","author":"U Rimon","year":"2006","unstructured":"Rimon, U. et al. Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding. Clin. Radiol. 61(6), 520\u2013526 (2006).","journal-title":"Clin. Radiol."},{"issue":"3","key":"87930_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00261-014-0083-3","volume":"39","author":"M Jinzaki","year":"2014","unstructured":"Jinzaki, M. et al. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 39(3), 588\u2013604 (2014).","journal-title":"Abdom Imaging"},{"issue":"3","key":"87930_CR32","doi-asserted-by":"publisher","first-page":"W137","DOI":"10.2214\/AJR.17.19120","volume":"210","author":"BK Park","year":"2018","unstructured":"Park, B. K. Reply to \u201cradiologic classification and imaging features of renal angiomyolipomas according to the amount of fat\u201d. AJR Am. J. Roentgenol. 210(3), W137\u2013W138 (2018).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"6","key":"87930_CR33","doi-asserted-by":"publisher","first-page":"W1076","DOI":"10.2214\/AJR.11.6922","volume":"197","author":"KD Song","year":"2011","unstructured":"Song, K. D., Kim, C. K., Park, B. K. & Kim, B. Utility of iodine overlay technique and virtual unenhanced images for the characterization of renal masses by dual-energy CT. AJR Am. J. Roentgenol. 197(6), W1076\u2013W1082 (2011).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1","key":"87930_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1148\/radiology.211.1.r99ap15283","volume":"211","author":"T Yoshizumi","year":"1999","unstructured":"Yoshizumi, T. et al. Abdominal fat: standardized technique for measurement at CT. Radiology 211(1), 283\u2013286 (1999).","journal-title":"Radiology"},{"key":"87930_CR35","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00261-020-02755-5","volume":"46","author":"AA Perez","year":"2020","unstructured":"Perez, A. A., Pickhardt, P. J., Elton, D. C., Sandfort, V. & Summers, R. M. Fully automated CT imaging biomarkers of bone, muscle, and fat: correcting for the effect of intravenous contrast. Abdom Radiol. (NY) 46, 1229\u20131235 (2020).","journal-title":"Abdom Radiol. (NY)"},{"issue":"6","key":"87930_CR36","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.urology.2005.06.119","volume":"66","author":"J Hafron","year":"2005","unstructured":"Hafron, J. et al. Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations. Urology 66(6), 1155\u20131159 (2005).","journal-title":"Urology"},{"issue":"3","key":"87930_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cpf.12422","volume":"38","author":"A van der Werf","year":"2018","unstructured":"van der Werf, A. et al. Skeletal muscle analyses: agreement between non-contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation. Clin. Physiol. Funct. Imaging 38(3), 366\u2013372 (2018).","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"87930_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.dib.2017.06.024","volume":"13","author":"T Higaki","year":"2017","unstructured":"Higaki, T. et al. Visualization of simulated small vessels on computed tomography using a model-based iterative reconstruction technique. Data Brief 13, 437\u2013443 (2017).","journal-title":"Data Brief"},{"issue":"8","key":"87930_CR39","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1007\/s00330-009-1358-x","volume":"19","author":"K Uotani","year":"2009","unstructured":"Uotani, K. et al. Dual-energy CT head bone and hard plaque removal for quantification of calcified carotid stenosis: utility and comparison with digital subtraction angiography. Eur. Radiol. 19(8), 2060\u20132065 (2009).","journal-title":"Eur. Radiol."},{"key":"87930_CR40","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.media.2019.101541","volume":"58","author":"N Tajbakhsh","year":"2019","unstructured":"Tajbakhsh, N., Shin, J. Y., Gotway, M. B. & Liang, J. Computer-aided detection and visualization of pulmonary embolism using a novel, compact, and discriminative image representation. Med. Image Anal. 58, 101541 (2019).","journal-title":"Med. Image Anal."},{"key":"87930_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fgene.2014.00187","volume":"5","author":"X Wang","year":"2014","unstructured":"Wang, X. Firth logistic regression for rare variant association tests. Front. Genet. 5, 187 (2014).","journal-title":"Front. Genet."},{"key":"87930_CR42","doi-asserted-by":"crossref","unstructured":"Shepherd CW, Gomez MR, Lie J, Crowson CS, (eds). Causes of death in patients with tuberous sclerosis. In Mayo Clinic Proceedings (Elsevier, 1991).","DOI":"10.1016\/S0025-6196(12)61196-3"},{"issue":"4","key":"87930_CR43","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","volume":"66","author":"MJ Eijkemans","year":"2015","unstructured":"Eijkemans, M. J. et al. Long-term Follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am. J. Kidney Dis. 66(4), 638\u2013645 (2015).","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"87930_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/dmcn.13352","volume":"59","author":"S Amin","year":"2017","unstructured":"Amin, S. et al. Causes of mortality in individuals with tuberous sclerosis complex. Dev. Med. Child. Neurol. 59(6), 612\u2013617 (2017).","journal-title":"Dev. Med. Child. Neurol."},{"issue":"4","key":"87930_CR45","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/ndt\/14.4.988","volume":"14","author":"A Clarke","year":"1999","unstructured":"Clarke, A., Hancock, E., Kingswood, C. & Osborne, J. P. End-stage renal failure in adults with the tuberous sclerosis complex. Nephrol. Dial. Transpl. 14(4), 988\u2013991 (1999).","journal-title":"Nephrol. Dial. Transpl."},{"issue":"12","key":"87930_CR46","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3111\/13696998.2015.1075995","volume":"18","author":"F Vekeman","year":"2015","unstructured":"Vekeman, F. et al. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J. Med. Econ. 18(12), 1060\u20131070 (2015).","journal-title":"J. Med. Econ."},{"key":"87930_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-014-0182-9","volume":"9","author":"JC Kingswood","year":"2014","unstructured":"Kingswood, J. C. et al. TOSCA\u2014first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex. Orphanet J. Rare Dis. 9, 182 (2014).","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"87930_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000448293","volume":"133","author":"JC Kingswood","year":"2016","unstructured":"Kingswood, J. C. et al. Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: current data and future study. Nephron 133(4), 51\u201358 (2016).","journal-title":"Nephron"},{"issue":"8","key":"87930_CR49","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1185\/03007995.2015.1060212","volume":"31","author":"J Bissler","year":"2015","unstructured":"Bissler, J. et al. Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma. Curr. Med. Res. Opin. 31(8), 1501\u20131507 (2015).","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"87930_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ndt\/gfv249","volume":"31","author":"JJ Bissler","year":"2016","unstructured":"Bissler, J. J. et al. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial. Nephrol. Dial Transplant. 31(1), 111\u2013119 (2016).","journal-title":"Nephrol. Dial Transplant."},{"issue":"2","key":"87930_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol. Cell 22(2), 159\u2013168 (2006).","journal-title":"Mol. Cell"},{"issue":"5","key":"87930_CR52","doi-asserted-by":"publisher","first-page":"F560","DOI":"10.1152\/ajprenal.00569.2013","volume":"307","author":"BJ Siroky","year":"2014","unstructured":"Siroky, B. J. et al. Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy. Am. J. Physiol. Renal Physiol. 307(5), F560\u2013F570 (2014).","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"17","key":"87930_CR53","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R. & Tee, A. R. mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34(17), 2239\u20132250 (2015).","journal-title":"Oncogene"},{"issue":"24","key":"87930_CR54","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.jacc.2009.01.072","volume":"53","author":"H Ota","year":"2009","unstructured":"Ota, H. et al. Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation. J. Am. Coll. Cardiol. 53(24), 2298\u20132305 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"87930_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"M Guba","year":"2002","unstructured":"Guba, M. et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat. Med. 8(2), 128\u2013135 (2002).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87930-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T11:16:03Z","timestamp":1675163763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87930"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87930-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8493"}}